Literature DB >> 19117365

Restless legs syndrome in multiple sclerosis: a case-control study.

Marcello Deriu1, Giovanni Cossu, Andrea Molari, Daniela Murgia, Alessandra Mereu, Paola Ferrigno, Davide Manca, Paolo Contu, Maurizio Melis.   

Abstract

The aim of our study was to explore restless legs syndrome (RLS) frequency in multiple sclerosis (MS)-patients and establish whether RLS could be a symptom of MS. Over a period of 1 year, we consecutively enrolled 202 MS-patients and 212 healthy controls, matched for sex and age, in a case-control study. All of them filled in a structured questionnaire according to IRLSSG criteria. Those patients who fit the diagnostic criteria were subsequently examined by a neurologist to verify the effective presence of RLS. A total of 91 MS-patients (45%) responded positively to the questionnaires. The diagnosis of RLS was carried out in 29 subjects (14.4%). Among the healthy controls, a definite diagnosis of RLS was achieved only in 6 subjects (2.8%). The risk of MS patients to present RLS was significantly higher (OR.5.76 P:0.00002) than the general population. None of them was affected by other medical conditions related to RLS developing. The 62 remaining patients presented numbness and weakness of the legs not suggestive of RLS. Our findings confirm a significant correlation between MS and RLS. In our opinion, MS must be definitively included among RLS causes.

Entities:  

Mesh:

Year:  2009        PMID: 19117365     DOI: 10.1002/mds.22431

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

1.  Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.

Authors:  Y Li; K L Munger; S Batool-Anwar; K De Vito; A Ascherio; X Gao
Journal:  Neurology       Date:  2012-04-25       Impact factor: 9.910

2.  Restless leg syndrome and multiple sclerosis: a case-control study in China.

Authors:  Gangqiong Liu; Xiao Feng; Chao Lan; Ziqiang Zhu; Shengli Ma; Yu Guo; Rui Xue
Journal:  Sleep Breath       Date:  2015-05-24       Impact factor: 2.816

3.  Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome.

Authors:  James R Connor; Padmavathi Ponnuru; Byeong-Yeul Lee; Gerald D Podskalny; Shoaib Alam; Richard P Allen; Christopher J Earley; Qing X Yang
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

4.  Restless legs syndrome heralding an acute exacerbation of multiple sclerosis.

Authors:  Takamichi Kanbayashi; Hisao Kamiya; Keiichi Hokkoku; Yuki Hatanaka; Masahiro Sonoo
Journal:  Neurol Sci       Date:  2014-07-05       Impact factor: 3.307

5.  Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.

Authors:  Montserrat González-Platas; Javier González-Platas; Moises Bermúdez-Hernández; Maria Yaiza Pérez-Martín; Cristina Croissier-Elías; Pedro Javier Pérez-Lorensu
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

6.  Restless legs syndrome in Iranian patients with multiple sclerosis.

Authors:  Shahnaz Miri; Mohammad Rohani; Mohammad Ali Sahraian; Babak Zamani; Gholam Ali Shahidi; Amin Sabet; Maziar Moradi-Lakeh; Mohammad Bodaghabadi
Journal:  Neurol Sci       Date:  2012-09-09       Impact factor: 3.307

Review 7.  A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

8.  Impact, Frequency, and Severity of Restless Legs Syndrome in Patients with Multiple Sclerosis in Argentina.

Authors:  Edgar Carnero Contentti; Pablo A López; Debora Nadur; María Eugenia Balbuena; Ana Mariel Finkelstein; Verónica Tkachuk
Journal:  Int J MS Care       Date:  2019 Jul-Aug

9.  Overview: A Framework for the Discussion of Sleep in Multiple Sclerosis.

Authors:  Tiffany J Braley
Journal:  Curr Sleep Med Rep       Date:  2017-10-28

10.  Restless Legs Syndrome in Multiple Sclerosis.

Authors:  Taşkın Güneş; Ufuk Emre; Yüksel Erdal; Osman Özgür Yalin
Journal:  Noro Psikiyatr Ars       Date:  2019-08-16       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.